In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI.
Rigolin GM, Cavallari M, Quaglia FM, Formigaro L, Lista E, Urso A, Guardalben E, Liberatore C, Faraci D, Saccenti E, Bassi C, Lupini L, Bardi MA, Volta E, Tammiso E, Melandri A, Negrini M, Cavazzini F, Cuneo A.
Rigolin GM, et al. Among authors: tammiso e.
Blood. 2017 Jun 29;129(26):3495-3498. doi: 10.1182/blood-2017-03-772285. Epub 2017 Apr 26.
Blood. 2017.
PMID: 28446433
Free article.
No abstract available.